Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Adaptin Bio (APTN) Share-based Compensation (2025 - 2026)

Adaptin Bio recorded quarterly Share-based Compensation of $345396.0 in Q1 2026, up 157.75% quarter-over-quarter from -$598136.0 in Q4 2025.

Adaptin Bio's Share-based Compensation history runs 2 years deep, the most recent figure standing at $345396.0 for Q1 2026.

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 345,396.00
Mar 31, 2026 345,396.00
Dec 31, 2025 -598,136.00
Dec 31, 2025 -598,136.00
Sep 30, 2025 320,125.00
Sep 30, 2025 320,125.00